[go: up one dir, main page]

FR2035765A1 - Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates - Google Patents

Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates

Info

Publication number
FR2035765A1
FR2035765A1 FR6906311A FR6906311A FR2035765A1 FR 2035765 A1 FR2035765 A1 FR 2035765A1 FR 6906311 A FR6906311 A FR 6906311A FR 6906311 A FR6906311 A FR 6906311A FR 2035765 A1 FR2035765 A1 FR 2035765A1
Authority
FR
France
Prior art keywords
heparinates
vitamin
pyridoxine
medicaments contg
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6906311A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INST RECH SCIENT
Original Assignee
INST RECH SCIENT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INST RECH SCIENT filed Critical INST RECH SCIENT
Priority to FR6906311A priority Critical patent/FR2035765A1/en
Priority to OA53864A priority patent/OA03002A/en
Priority to DE19702010172 priority patent/DE2010172A1/en
Priority to BE746855D priority patent/BE746855A/en
Publication of FR2035765A1 publication Critical patent/FR2035765A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Title compsns. contain pyridoxine, pyridoxamine or pyridoxal heparinates opt. with antiinflammatory enzymes corticosteroids, Vitamin P and a hypolipaemic agent and are useful as anticoagulant, antiinflammatory and hypolipaemic agents.
FR6906311A 1969-03-06 1969-03-06 Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates Withdrawn FR2035765A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR6906311A FR2035765A1 (en) 1969-03-06 1969-03-06 Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
OA53864A OA03002A (en) 1969-03-06 1970-03-04 Process for preparing an anticoagulant, anti-inflammatory and plasma-clarifying product, based on pyridoxine heparinate.
DE19702010172 DE2010172A1 (en) 1969-03-06 1970-03-04 Medicines with anticoagulant, anti-inflammatory and plasma-clearing properties
BE746855D BE746855A (en) 1969-03-06 1970-03-05 ANTICOAGULANT, ANTI-INFLAMMATORY AND PLASMATIC CLARIFIER, BASED ON PYRIDOXINE HEPARINATE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6906311A FR2035765A1 (en) 1969-03-06 1969-03-06 Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates

Publications (1)

Publication Number Publication Date
FR2035765A1 true FR2035765A1 (en) 1970-12-24

Family

ID=9030230

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6906311A Withdrawn FR2035765A1 (en) 1969-03-06 1969-03-06 Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates

Country Status (4)

Country Link
BE (1) BE746855A (en)
DE (1) DE2010172A1 (en)
FR (1) FR2035765A1 (en)
OA (1) OA03002A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931002A (en) * 1987-05-29 1990-06-05 The University Of Vermont Pyridoxal-5'-phosphate as an in vitro anticoagulant for whole blood

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3705549A1 (en) * 1987-02-18 1988-09-01 Ulrich Speck USE OF PYRIDOXINE DERIVATIVES IN THE PROPHYLAXIS AND THERAPY OF HYPERLIPIDAEMIA AND ATHEROSCLEROSIS
US5514667A (en) * 1990-11-05 1996-05-07 Arthropharm Pty. Limited Method for topical treatment of herpes infections
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment
DE20101724U1 (en) 2001-02-01 2001-04-26 Wiedner, Klaus, Dipl.-Kfm., 90768 Fürth glasses

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931002A (en) * 1987-05-29 1990-06-05 The University Of Vermont Pyridoxal-5'-phosphate as an in vitro anticoagulant for whole blood

Also Published As

Publication number Publication date
OA03002A (en) 1970-12-15
DE2010172A1 (en) 1970-09-24
BE746855A (en) 1970-08-17

Similar Documents

Publication Publication Date Title
AU534282B2 (en) Selective diversion by ball sealers in bores
CA953862A (en) Extrusionied for plastic film, and method
CA983376A (en) Packaging machine for individual portions, and method
CA995120A (en) Method for bonding surfaces together
CA958627A (en) Veneer lathe charger
FR2035765A1 (en) Medicaments contg pyridoxine heparinates or - other vitamin b6 heparinates
CA990842A (en) Frequency controlled, passively q-switched laser
IE34683B1 (en) Benzyl-pyrimidine derivatives and a process for the manufacture thereof
BE790118A (en) PYRIDOXAL AND PYRIDOXAMINE ALPHA-CETOGLUTARATE DERIVATIVES,
CA976169A (en) 2,3,6-substituted triamino pyridine compounds
CA972501A (en) Synthetic vascular graft and method for manufacturing the same
CA824043A (en) Endless track
ATE30425T1 (en) ISOXAZOLE (5,4-B) PYRIDINE.
CA891533A (en) Glasses, glass-ceramics, and method
CA908195A (en) Glasses, glass-ceramics, and method
CA950464A (en) Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas
CA914683A (en) Sulfur-containing pyridines and process for the production thereof
ZA727621B (en) Derivatives of alpha-ketoglutaric acid,pyridoxal alpha-ketoglutarate and pyridoxamine alpha-ketoglutarate
CA825061A (en) Endless track drive
CA811406A (en) Track pin bushing
CA862579A (en) Packaging, method therefor, and machine for automatically carrying out the method
CA917656A (en) N-oxides of 5-(aminoalkyl)-5,11-dihydrodibenzoxazepines and 5,11-dihydrodibenzthiazepines
CA831013A (en) Pyridine-2,6-dimethanol mono-n-alkyl carbamates
CA910587A (en) Method of agglomerating finely divided, inorganic phosphates
CA829571A (en) Machine for cutting, forming and inserting components

Legal Events

Date Code Title Description
ST Notification of lapse